{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:34:13Z","timestamp":1770276853848,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00467-023-05887-0","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T13:43:30Z","timestamp":1676295810000},"page":"2763-2770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Short-term safety and efficacy of escalating doses of atorvastatin for dyslipidemia in children with predialysis chronic kidney disease stage 2\u20135"],"prefix":"10.1007","volume":"38","author":[{"given":"Punitha Lakxmi","family":"Ramesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lakshmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"5887_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.semnephrol.2018.08.002","volume":"38","author":"DJ Weaver","year":"2018","unstructured":"Weaver DJ, Mitsnefes M (2018) Cardiovascular disease in children and adolescents with chronic kidney disease. Semin Nephrol 38:559\u2013569","journal-title":"Semin Nephrol"},{"key":"5887_CR2","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1161\/CIR.0000000000000618","volume":"139","author":"SD de Ferranti","year":"2019","unstructured":"de Ferranti SD, Steinberger J, Ameduri R, Baker A, Gooding H, Kelly AS et al (2019) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association. Circulation 139:e603\u2013e634","journal-title":"Circulation"},{"key":"5887_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1053\/j.ajkd.2012.07.018","volume":"60","author":"CJ Wong","year":"2012","unstructured":"Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL (2012) CKiD (CKD in Children) Prospective cohort study: a review of current findings. Am J Kidney Dis 60:1002\u20131011","journal-title":"Am J Kidney Dis"},{"key":"5887_CR4","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.2215\/CJN.03110319","volume":"14","author":"JM Saland","year":"2019","unstructured":"Saland JM, Kupferman JC, Pierce CB, Flynn JT, Mitsnefes MM, Warady BA et al (2019) Change in dyslipidemia with declining glomerular filtration rate and increasing proteinuria in children with CKD. Clin J Am Soc Nephrol 14:1711\u20131718","journal-title":"Clin J Am Soc Nephrol"},{"key":"5887_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00467-020-04545-z","volume":"35","author":"HS Baek","year":"2020","unstructured":"Baek HS, Kim SH, Kang HG, Choi HJ, Cheong HI, Ha IS et al (2020) Dyslipidemia in pediatric CKD patients: results from KNOW-pedCKD (Korean cohort study for Outcomes in patients With Pediatric CKD). Pediatr Nephrol 35:1455\u20131461","journal-title":"Pediatr Nephrol"},{"key":"5887_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/CJN.01090216","volume":"12","author":"F Schaefer","year":"2017","unstructured":"Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A et al (2017) Cardiovascular phenotypes in children with CKD: the 4C study. Clin J Am Soc Nephrol 12:19\u201328","journal-title":"Clin J Am Soc Nephrol"},{"key":"5887_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00467-016-3350-4","volume":"31","author":"P Khandelwal","year":"2016","unstructured":"Khandelwal P, Murugan V, Hari S, Lakshmy R, Sinha A, Hari P et al (2016) Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease. Pediatr Nephrol 31:1313\u20131320","journal-title":"Pediatr Nephrol"},{"key":"5887_CR8","doi-asserted-by":"publisher","first-page":"e012143","DOI":"10.1161\/JAHA.119.012143","volume":"8","author":"IF Ashoor","year":"2019","unstructured":"Ashoor IF, Mansfield SA, O\u2019Shaughnessy MM, Parekh RS, Zee J, Vasylyeva TL et al (2019) Prevalence of cardiovascular disease risk factors in childhood glomerular diseases. J Am Heart Assoc 8:e012143","journal-title":"J Am Heart Assoc"},{"key":"5887_CR9","first-page":"e1187","volume":"139","author":"SM Grundy","year":"2018","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al (2018) AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/apha\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139:e1187","journal-title":"Circulation"},{"key":"5887_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1542\/peds.2009-2107C","volume":"128","author":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents","year":"2011","unstructured":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents (2011) National Heart, Lung, and Blood Institute summary report. Pediatrics 128:13\u201356","journal-title":"Pediatrics"},{"key":"5887_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1053\/j.ajkd.2014.10.005","volume":"65","author":"MJ Sarnak","year":"2015","unstructured":"Sarnak MJ, Bloom R, Muntner P, Rahman M, Saland JM, Wilson PWF et al (2015) KDOQI US commentary on the 2013 KDIGO clinical practice guideline for lipid management in CKD. Am J Kidney Dis 65:354\u2013366","journal-title":"Am J Kidney Dis"},{"key":"5887_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"5887_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","volume":"85","author":"M de Onis","year":"2007","unstructured":"de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85:660\u2013667","journal-title":"Bull World Health Organ"},{"key":"5887_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4103\/2230-8210.159028","volume":"19","author":"VV Khadilkar","year":"2015","unstructured":"Khadilkar VV, Khadilkar AV (2015) Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5\u201318-year-old Indian children. Indian J Endocrinol Metab 19:470\u2013476","journal-title":"Indian J Endocrinol Metab"},{"key":"5887_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tcm.2019.05.003","volume":"30","author":"JM Flack","year":"2020","unstructured":"Flack JM, Adekola B (2020) Blood pressure and the new ACC\/AHA hypertension guidelines. Trends Cardiovasc Med 30:160\u2013164","journal-title":"Trends Cardiovasc Med"},{"key":"5887_CR16","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904","journal-title":"Pediatrics"},{"key":"5887_CR17","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt K-U, Tsukamoto Y, Levin A, Coresh J, Rossert J et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease Improving Global Outcomes (KDIGO). Kidney Int 67:2089\u20132100","journal-title":"Kidney Int"},{"key":"5887_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/clinchem\/22.2.188","volume":"22","author":"PW Wentz","year":"1976","unstructured":"Wentz PW, Cross RE, Savory J (1976) An integrated approach to lipid profiling: enzymatic determination of cholesterol and triglycerides with a centrifugal analyzer. Clin Chem 22:188\u2013192","journal-title":"Clin Chem"},{"key":"5887_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/clinchem\/22.1.98","volume":"22","author":"BW Steele","year":"1976","unstructured":"Steele BW, Koehler DF, Azar MM, Blaszkowski TP, Kuba K, Dempsey ME (1976) Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique. Clin Chem 22:98\u2013101","journal-title":"Clin Chem"},{"key":"5887_CR20","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","volume":"317","author":"MH Frick","year":"1987","unstructured":"Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P et al (1987) Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317:1237\u20131245","journal-title":"N Engl J Med"},{"key":"5887_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"5887_CR22","first-page":"90","volume":"112","author":"A Freites-Martinez","year":"2021","unstructured":"Freites-Martinez A, Santana N, Arias-Santiago S, Viera A (2021) Using the Common Terminology Criteria for Adverse Events (CTCAE - version 5.0) to evaluate the severity of adverse events of anticancer therapies. Actas Dermosifiliogr (Engl Ed) 112:90\u201392","journal-title":"ActasDermosifiliogr (Engl Ed)"},{"key":"5887_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11096-018-0694-9","volume":"40","author":"SK Behera","year":"2018","unstructured":"Behera SK, Das S, Xavier AS, Velupula S, Sandhiya S (2018) Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm 40:903\u2013910","journal-title":"Int J Clin Pharm"},{"key":"5887_CR24","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ et al (2016) ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J 37:2999\u20133058","journal-title":"Eur Heart J"},{"key":"5887_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","volume":"289","author":"PD Thompson","year":"2003","unstructured":"Thompson PD (2003) Statin-associated myopathy. JAMA 289:1681","journal-title":"JAMA"},{"key":"5887_CR26","first-page":"433","volume":"32","author":"K Gandelman","year":"2011","unstructured":"Gandelman K, Glue P, Laskey R, Jones J, Labadie R, Ose L (2011) An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia. Pediatr Cardiol 32:433\u2013441","journal-title":"PediatrCardiol"},{"key":"5887_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0022-3476(03)00186-0","volume":"143","author":"BW McCrindle","year":"2003","unstructured":"McCrindle BW, Ose L, Marais AD (2003) Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 143:74\u201380","journal-title":"J Pediatr"},{"key":"5887_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","volume":"4","author":"WG Herrington","year":"2016","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration, Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD et al (2016) Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet Diabetes Endocrinol 4:829\u2013839","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5887_CR29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00467-009-1128-7","volume":"24","author":"S Garc\u00eda-de-la-Puente","year":"2009","unstructured":"Garc\u00eda-de-la-Puente S, Luis Arredondo-Garc\u00eda J, Guti\u00e9rrez-Castrell\u00f3n P, Bojorquez-Ochoa A, Reyna Maya E, Del Pilar P-M (2009) Efficacy of simvastatin in children with hyperlipidemia secondary to kidney disorders. Pediatr Nephrol 24:1205\u20131210","journal-title":"Pediatr Nephrol"},{"key":"5887_CR30","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00467-018-4036-x","volume":"33","author":"P Hari","year":"2018","unstructured":"Hari P, Khandelwal P, Satpathy A, Hari S, Thergaonkar R, Lakshmy R et al (2018) Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial. Pediatr Nephrol 33:2299\u20132309","journal-title":"Pediatr Nephrol"},{"key":"5887_CR31","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1161\/ATVBAHA.107.145151","volume":"27","author":"HJ Avis","year":"2007","unstructured":"Avis HJ, Vissers MN, Stein EA, Wijburg FA, Trip MD, Kastelein JJP et al (2007) A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 27:1803\u20131810","journal-title":"ArteriosclerThrombVasc Biol"},{"key":"5887_CR32","doi-asserted-by":"publisher","first-page":"41481","DOI":"10.1038\/srep41481","volume":"7","author":"JLC Anderson","year":"2017","unstructured":"Anderson JLC, Gautier T, Nijstad N, T\u00f6lle M, Schuchardt M et al (2017) High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport. Sci Rep 7:41481","journal-title":"Sci Rep"},{"key":"5887_CR33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1161\/ATVBAHA.113.301235","volume":"33","author":"V Binder","year":"2013","unstructured":"Binder V, Ljubojevic S, Haybaeck J, Holzer M, El-Gamal D et al (2013) The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors. Arterioscler Thromb Vasc Biol 33:1020\u20131027","journal-title":"ArteriosclerThrombVasc Biol"},{"key":"5887_CR34","first-page":"1043","volume":"17","author":"M Holzer","year":"2012","unstructured":"Holzer M, Zangger K, El-Gamal D, Binder V, Curcic S et al (2012) Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein. Antioxid Redox Signal 17:1043\u20131052","journal-title":"AntioxidRedox Signal"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05887-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-05887-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05887-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T07:12:23Z","timestamp":1690873943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-05887-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["5887"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-05887-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"13 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}